Amylin and Takeda Halt Phase II Obesity Trial
Firms uncovered neutralizing antibodies to leptin, which is one part of the combination drug under evaluation. Amylin Pharmaceuticals and Takeda Pharmaceutical have suspended an ongoing Phase II trial examinin…
Read guide →